Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma.

Peng SC, Liao CT, Peng CH, Cheng AJ, Chen SJ, Huang CG, Hsieh WP, Yen TC.

PLoS One. 2014 Jul 22;9(7):e102403. doi: 10.1371/journal.pone.0102403.

2.

Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.

Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, Munirajan AK.

Mol Cancer. 2016 Apr 7;15:28. doi: 10.1186/s12943-016-0512-8.

3.

Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.

Manikandan M, Deva Magendhra Rao AK, Rajkumar KS, Rajaraman R, Munirajan AK.

J Oral Pathol Med. 2015 Nov;44(10):792-800. doi: 10.1111/jop.12300.

PMID:
25482863
4.

Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.

Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren Y, Liu W, Li N.

Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z.

PMID:
26224475
5.

Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma.

Liao L, Wang J, Ouyang S, Zhang P, Wang J, Zhang M.

Med Sci Monit. 2015 Mar 16;21:776-81. doi: 10.12659/MSM.892508.

6.

MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma.

Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, Uzawa K, Ito H, Takiguchi Y, Tanzawa H.

Br J Cancer. 2013 May 14;108(9):1817-21. doi: 10.1038/bjc.2013.175.

7.

Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.

Ni ZY, Lin FO, Liu DF, Xiao J.

Genet Mol Res. 2015 Jun 26;14(2):6943-52. doi: 10.4238/2015.June.26.2. Retraction in: Genet Mol Res. 2016 Dec 01;15(4):.

8.

MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen JA, Krogdahl A, Clark SJ, Kjems J.

PLoS One. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840.

9.

Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.

Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM.

Genes Chromosomes Cancer. 2009 Jul;48(7):569-82. doi: 10.1002/gcc.20666.

10.

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.

Cancer Res. 2008 Apr 1;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.

11.

MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival.

Hedbäck N, Jensen DH, Specht L, Fiehn AM, Therkildsen MH, Friis-Hansen L, Dabelsteen E, von Buchwald C.

PLoS One. 2014 Apr 22;9(4):e95193. doi: 10.1371/journal.pone.0095193.

12.

MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.

Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y, Bao ZX, Jiang WW.

Head Neck. 2015 Jul;37(7):970-6. doi: 10.1002/hed.23700.

PMID:
24692283
13.
14.

Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.

Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M.

PLoS One. 2012;7(3):e33762. doi: 10.1371/journal.pone.0033762.

15.

HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.

Sterenczak KA, Eckardt A, Kampmann A, Willenbrock S, Eberle N, Länger F, Kleinschmidt S, Hewicker-Trautwein M, Kreipe H, Nolte I, Murua Escobar H, Gellrich NC.

BMC Cancer. 2014 Sep 23;14:694. doi: 10.1186/1471-2407-14-694.

16.

Prognostic significance of differentially expressed miRNAs in esophageal cancer.

Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC.

Int J Cancer. 2011 Jan 1;128(1):132-43. doi: 10.1002/ijc.25330.

17.

Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.

Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, Chen YW.

Mol Cancer. 2014 Jan 10;13:6. doi: 10.1186/1476-4598-13-6.

18.

miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.

Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW.

Oral Oncol. 2010 Mar;46(3):204-8. doi: 10.1016/j.oraloncology.2009.12.005.

PMID:
20138800
19.

Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.

Chen SJ, Liu H, Liao CT, Huang PJ, Huang Y, Hsu A, Tang P, Chang YS, Chen HC, Yen TC.

Oncotarget. 2015 Jul 20;6(20):18066-80.

20.

Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.

Jensen DH, Dabelsteen E, Specht L, Fiehn AM, Therkildsen MH, Jønson L, Vikesaa J, Nielsen FC, von Buchwald C.

J Pathol. 2015 Aug;236(4):505-16. doi: 10.1002/path.4550.

PMID:
25925492

Supplemental Content

Support Center